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Abstract: Gardi -5 has been used in traditional Mongolian medicine as an analgesic and antibacterial 
medicine. The drug has been studied in chemical-pharmacological research. We have a new natural patch 
from the prepared Gardi-5. The present work was undertaken to evaluate the traditional drug Gardi patch 
for its anti-inflammatory activity.
The method of Miho Sekiquichi was used to study acute inflammation. Rats in groups of five each were treated 
with vehicle, Gardi patch and Ketoprofen patch one hour prior to Carrageenan injection. 0.1 ml of 1% 
Carrageenan was injected into the sub plantar tissue of left hind paw of each rat. Swelling of carrageenan 
injected foot was measured at 0, 30, 60, 120, 180, 240, 300 mins using Plethysmometer (UGO Basile, Italy). 
The right hind paw was injected with 0.1 ml of vehicle.
The Gardi patch significantly (p=0.000) inhibited carrageenan induced rat paw edema as compared to 
control group. In assay data, the TNF-α, PGE2 secretion in serum were highly elevated by carrageenan 
induction but administration of Gardi patch significantly reduced serum secretion of inflammatory mediators 
as compared to vehicle group. Gardi patch has an anti-inflammatory properties.




Garidi-5 has been used in traditional Mongolian 
medicine as an antibacterial and analgesic 
agent for treatments of various diseases 
including typhus, dyphteria, joint conditions, 
neurological and skin disorders. Garidi-5 is 
composed of 5 herbs including Terminalia 
chebula Retz., Aconitum Kusnezoffii Reichb., 
Acorus calamus L.,Saussurea lappa L., 
and musk of Moschus moschiferus.[1,2] As 
written in traditional medical sourcebooks 
the compounds of Gairidi-5 mainly balance 
humors, detoxify the body, kill bacteria and 
relieve pain [3]. The drug has been studied 
chemical-pharmacological research. We have 
a new natural patch from the prepared Gardi-5. 
In this study, using the carrageenan-
induced rat paw pad edema model, we 
evaluated the anti-inflammatory effect of a 
10% Gardi patch. The effect of the Gardi patch 
was compared to with commercially available 
3.75% Ketoprofen-containing patches.
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MATERIAL AND METHODS
Animals: A total male 50 Wistar rats (180-
220 g) were used for the study and all were 
housed in a quiet room with 12 h light/dark 
cycle. All experiments were approved by 
the Animal Studies Committee at Institute 
of Traditional medicine and technology of 
Mongolia.
Material: Gardi patch produced in 
of Institute of Traditional Medicine and 
Technology of Mongolia, was used in this 
study. 
Anti-Inflammatory Study. Wistar male rats 
(aged 5 weeks) were measured for the volume 
of the right hind footpad paw in advance with 
the paw volume-measuring instrument, and 50 
randomly selected rats were assigned to groups 
(10 animals in each group). The measured paw 
volumes were handled as the baseline values. 
In each study, a piece of drug patch was applied 
at the back center of the right hind footpad paw 
of each rat and fixed with Band-Aid. 
During the treatment, the drug patch was 
removed at 2 hours after application, and 
0.1 mL of an aqueous 1 w/v% suspension 
of λ-carrageenan in physiological saline 
was injected subcutaneously into the right 
hind footpad paw pad as an inflammation-
inducing agent. In the inflammation control 
group, no drug patch was applied, and 
only the inflammation-inducing agent was 
administered. At 0, 30, 60, 120, 180, 240, 300 
minutes after the induction of inflammation, 
the paw volume was measured, and the edema 
rate (%) was calculated using the baseline 
value. Swelling of carrageenan injected foot 
was measured at 0, 30, 60, 120, 180, 240, 
300 min using Plethysmometer (UGO Basile, 
Italy). Furthermore, efficacy of treatment with 
use of 1% carrageenan was found according to 
PGE2 and TNF α level. Blood samples were 
collected via cardiac puncture at 0, 30, 60, 
120, 180, 240, 300 after the administration of 
carrageenan and from healthy rats. 
All rats were euthanized with phenobarbital 
sodium before blood collection. The collected 
blood samples were centrifuged at 377.3 g for 
10 min at 4°C, and the plasma supernatant 
was stored at –20°C until further analysis. 
The plasma levels of TNF-a and PGE2 were 
detected using solid-phase sandwich enzyme-
linked immune sorbent assay (ELISA, 
Shanghai MLBIO Biotechnology Co. Ltd.) 
kits specific for the detection of these factors, 
and the absorbance was measured at 450 nm 
by a plate reader (Chromate 4300 micro plate, 
Shanghai MLBIO Biotechnology Co. Ltd., 
China). 
In the study used 10% (100 mg) Gardi 
patch, 3.5% (133 mg) Ketoprofen patch (Patex 
® , Nipro Patch Co., Ltd). Since the density of 
each drug imbedded in the sheet differed, the 
applied dose was controlled by standardizing 
sheet size in this study at 2.0 cm × 1.75 cm, 
based on the relative difference between 
human and rat body sizes [4-6]. 
Statistical analysis
Data are reported as means±SD. Statistical 
significance was determined by one-way 
analysis of variance followed by Tukey’s 
multiple comparison test. A P value 0.05 was 
considered statistically significant. 
RESULTS 
Carrageenan induced rat paw edema
In the control group, the edema rate 
increased with time after induction of 
inflammation with a maximum at 5-6 hours 
(Figure 1).
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Figure 1. Anti-inflammatory effect (AUEC: Area under the effect curve) of 10% diclofenac patch or other 
NSAID patch on the carrageenan-induced hind footpad paw edema in rats 
In the  Gardi patch group, the edema rates 
were lower than those in the inflammation 
control group as well as in the Ketoprofen 
group from 1 hour after induction of 
inflammation, and a significant difference was 
seen between the  Gardi patch group and the 
inflammation control group (p=0.009) at 6 
hours after induction of inflammation. 
Effect of Gardi patch on the expression of 
pro-inflammatory cytokines of plasma,
Effect of Gardi patch on the expression of 
pro-inflammatory cytokines of plasma. In the 
control group, the levels PGE2 significantly 
increased after carrageenan administration and 
reached peak levels at 300 min. 
Figure 2. Changes in the levels of pro-inflammatory cytokines
A, Interleukin (IL-6); B, tumor necrosis 
factor (TNF a)
However, the levels of the late stage pro-
inflammatory cytokine TNF-a increased 
gradually and reached a peak at 60 min. 
In contrast, the rats treated with Gardi 
patch had significantly lower levels of 
PGE2  (Carrageenan+Gardi patch group vs 
Carrageenan group: p=0.05 at 60, 120 and 240 
min) and of TNF-a (p=0.05 at 120, 180, 240, 
and 300 min) (Figure 2). Statistical analysis 
revealed that Gardi patch and Ketoprofen 
significantly inhibited the development of 
edema 0-300 min after treatment (Fig. 2) and 
they both showed anti-inflammatory effects in 
Carrageenan induced rat paw edema.
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DISCUSSION
This study was performed to evaluate 
the putative anti-inflammatory activities of 
Gardi patch, using various animal model 
to inflammation effects. The injection of 
Carrageenan into mice produces a typical 
biphasic edema associated with the production 
of several inflammatory mediators, including 
bradykinin, prostaglandins and cytokines. 
The first phase peaks at 3 h and the delayed 
phase peaks at 48 h after Carrageenan injection 
[7.8]. Development of edema induced by 
Carrageenan is commonly correlated with the 
early exudates stage of inflammation, which is 
one of the important processes of inflammatory 
pathology [9.10].  
It was found that the injection of 
Carrageenan into the mice paw induced the 
liberation of bradykinin, which later induced 
the biosynthesis of PGE2 and other autacoids 
that are responsible for the formation of the 
inflammatory exudates [11-14]. We also 
evaluated the anti-inflammatory effects 
of Gardi patch on paw edema induced by 
Carrageenan in mice and detected the levels of 
TNF-α and PGE2  the paw edema 0-300 min 
after Carrageenan injection. It is clear from 
(figure 2).  
Statistical analysis revealed that Gardi 
patch and Ketoprofen significantly inhibited 
the development of edema 0-300 min after 
treatment (Fig. 2) and they both showed anti-
inflammatory effects in Carrageenan induced 
rat paw edema. In the current study, the 
levels of TNF-α and PGE2 were decreased 
significantly of Gardi patch.
CONCLUSION
The results of this study showed that, 
in addition to the potent PGE2 and TNF 
α inhibiting activity and   the Gardi patch 
was effective in decrease paw edema in 
Carrageenan induced rat paw edema model. 
Gardi patch has an anti-inflammatory effects.
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